Lipoproteomics II: Mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry
- 31 March 2005
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 5 (5), 1431-1445
- https://doi.org/10.1002/pmic.200401010
Abstract
High-density lipoprotein (HDL) is the most abundant lipoprotein particle in the plasma and a negative risk factor of atherosclerosis. By using a proteomic approach it is possible to obtain detailed information about its protein content and protein modifications that may give new information about the physiological roles of HDL. In this study the two subfractions; HDL2 and HDL3, were isolated by two-step discontinuous density-gradient ultracentrifugation and the proteins were separated with two-dimensional gel electrophoresis and identified with peptide mass fingerprinting, using matrix-assisted laser desorption/ionisation time of flight mass spectrometry. Identified proteins in HDL were: the dominating apo A-I as six isoforms, four of them with a glycosylation pattern and one of them with retained propeptide, apolipoprotein (apo) A-II, apo A-IV, apo C-I, apo C-II, apo C-III (two isoforms), apo E (five isoforms), the recently discovered apo M (two isoforms), serum amyloid A (two isoforms) and serum amyloid A-IV (six isoforms). Furthermore, alpha-1-antitrypsin was identified in HDL for the first time. Additionally, salivary alpha-amylase was identified as two isoforms in HDL2, and apo L and a glycosylated apo A-II were identified in HDL3. Besides confirming the presence of different apolipoproteins, this study indicates new patterns of glycosylated apo A-I and apo A-II. Furthermore, the study reveals new proteins in HDL; alpha-1-antitrypsin and salivary alpha-amylase. Further investigations about these proteins may give new insight into the functional role of HDL in coronary artery diseases.Keywords
This publication has 43 references indexed in Scilit:
- Apolipoprotein B and apolipoprotein A‐I: risk indicators of coronary heart disease and targets for lipid‐modifying therapyJournal of Internal Medicine, 2004
- Emerging importance of HDL cholesterol in developing high-risk coronary plaques in acute coronary syndromesCurrent Opinion in Cardiology, 2003
- High-density lipoprotein subpopulations in pathologic conditionsThe American Journal of Cardiology, 2003
- HDL in atherosclerosis: actor or bystander?Atherosclerosis Supplements, 2003
- Inflammatory Reactions in the Pathogenesis of AtherosclerosisJournal of Atherosclerosis and Thrombosis, 2003
- ProteinChip Technology: A New and Facile Method for the Identification and Measurement of High-Density Lipoproteins apoA-I and apoA-II and Their Glycosylated Products in Patients with Diabetes and Cardiovascular DiseaseJournal of Proteome Research, 2002
- High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation?Autoimmunity Reviews, 2002
- Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery diseaseThe American Journal of Cardiology, 2001
- In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functionsJournal of Lipid Research, 2001
- Proteomics: new perspectives, new biomedical opportunitiesThe Lancet, 2000